• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热休克蛋白70肽与自然杀伤细胞的相互作用涉及自然杀伤细胞受体CD94。

Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94.

作者信息

Gross Catharina, Hansch Daniel, Gastpar Robert, Multhoff Gabriele

机构信息

Department of Hematology and Oncology, University Hospital Regensburg, Franz-Josef Strauss Allee 11, D-93053 Regensburg, Germany.

出版信息

Biol Chem. 2003 Feb;384(2):267-79. doi: 10.1515/BC.2003.030.

DOI:10.1515/BC.2003.030
PMID:12675520
Abstract

Full-length Hsp70 protein (Hsp70) and the C-terminal domain of Hsp70 (Hsp70C) both stimulate the cytolytic activity of naive natural killer (NK) cells against Hsp70-positive tumor target cells. Here, we describe the characterization of Hsp70-NK cell interaction with binding studies using the human NK cell line YT. Binding of recombinant Hsp70 protein (Hsp70) and the C-terminal domain of Hsp70 (Hsp70C) to YT cells is demonstrated by immunofluorescence studies. A phenotypic characterization revealed that none of the recently described HSP-receptors (alpha2-macroglobulin receptor CD91, Toll-like receptors 2, 4, 9, CD14) are expressed on YT cells. Only the C-type lectin receptor CD94 is commonly expressed by YT cells and Hsp70 reactive NK cells. A correlation of the cell density-dependent, variable CD94 expression and the binding capacity of Hsp70 was detected. Furthermore, Hsp70 binding could be completely abrogated by preincubation of YT cells with a CD94-specific antibody. Competition assays using either unlabeled Hsp70 protein or an unrelated protein (GST) in 20-fold excess and binding studies with escalating doses of Hsp70 protein provide evidence for a specific and concentration-dependent interaction of Hsp70 with YT cells. In addition to Hsp70 and Hsp70C, a 14-mer Hsp70 peptide termed TKD is known to exhibit comparable stimulatory properties on NK cells. Similar to full-length Hsp70 protein (10 microg/ml-50 microg/ml), a specific binding of this peptide to YT cells was observed at 4 degrees C, at equivalent concentrations (2.0 microg/ml-8.0 microg/ml). Following a 30 min incubation period at 37 degrees C, membrane-bound Hsp70 protein and Hsp70 peptide TKD were completely taken up into the cytoplasm.

摘要

全长热休克蛋白70(Hsp70)和热休克蛋白70的C末端结构域(Hsp70C)均能刺激天然幼稚自然杀伤(NK)细胞对Hsp70阳性肿瘤靶细胞的细胞溶解活性。在此,我们通过使用人NK细胞系YT进行结合研究来描述Hsp70与NK细胞相互作用的特征。免疫荧光研究证实重组热休克蛋白70(Hsp70)和热休克蛋白70的C末端结构域(Hsp70C)与YT细胞的结合。表型特征显示,最近描述的热休克蛋白受体(α2-巨球蛋白受体CD91、Toll样受体2、4、9、CD14)在YT细胞上均未表达。只有C型凝集素受体CD94在YT细胞和Hsp70反应性NK细胞中普遍表达。检测到细胞密度依赖性、可变的CD94表达与Hsp70的结合能力之间的相关性。此外,用CD94特异性抗体预孵育YT细胞可完全消除Hsp70的结合。使用未标记的Hsp70蛋白或20倍过量的无关蛋白(GST)进行竞争试验以及用递增剂量的Hsp70蛋白进行结合研究,为Hsp70与YT细胞的特异性和浓度依赖性相互作用提供了证据。除了Hsp70和Hsp70C外,一种名为TKD的14聚体Hsp70肽已知对NK细胞具有类似的刺激特性。与全长热休克蛋白70(10μg/ml - 50μg/ml)相似,在4℃下,该肽在等效浓度(2.0μg/ml - 8.0μg/ml)时与YT细胞发生特异性结合。在37℃孵育30分钟后,膜结合的热休克蛋白70和热休克蛋白70肽TKD被完全摄取到细胞质中。

相似文献

1
Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94.热休克蛋白70肽与自然杀伤细胞的相互作用涉及自然杀伤细胞受体CD94。
Biol Chem. 2003 Feb;384(2):267-79. doi: 10.1515/BC.2003.030.
2
Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.用体外热休克蛋白70-肽激活的自体自然杀伤细胞治疗结肠癌和肺癌患者:一项I期临床试验。
Clin Cancer Res. 2004 Jun 1;10(11):3699-707. doi: 10.1158/1078-0432.CCR-03-0683.
3
Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells.热休克蛋白70反应性与原发性自然杀伤细胞上CD94/CD56的细胞表面密度增加相关。
Cell Stress Chaperones. 2003 Winter;8(4):348-60. doi: 10.1379/1466-1268(2003)008<0348:hspria>2.0.co;2.
4
Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells.重度联合免疫缺陷小鼠肿瘤生长的抑制是由热休克蛋白70(Hsp70)肽激活的、CD94阳性自然杀伤细胞介导的。
Cell Stress Chaperones. 2002 Oct;7(4):365-73. doi: 10.1379/1466-1268(2002)007<0365:IOTGIM>2.0.CO;2.
5
The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor.人类自然杀伤细胞CD94/NKG2A抑制性受体的细胞生物学
Mol Immunol. 2005 Feb;42(4):485-8. doi: 10.1016/j.molimm.2004.07.031.
6
The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.抑制性自然杀伤细胞受体CD94/NKG2A和激活性受体CD94/NKG2C通过大部分共享但部分不同的HLA-E残基集合与HLA-E的顶部结合。
Eur J Immunol. 2004 Jan;34(1):81-90. doi: 10.1002/eji.200324432.
7
An Hsp70 peptide initiates NK cell killing of leukemic blasts after stem cell transplantation.一种热休克蛋白70(Hsp70)肽在干细胞移植后启动自然杀伤细胞对白血病原始细胞的杀伤作用。
Leuk Res. 2008 Apr;32(4):527-34. doi: 10.1016/j.leukres.2007.03.027. Epub 2007 May 31.
8
Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.蜕膜CD56bright自然杀伤细胞上凝集素样自然杀伤受体、抑制性CD94/NKG2A和激活性CD94/NKG2C的表达模式与外周CD56dim自然杀伤细胞上的不同。
J Reprod Immunol. 2006 Jun;70(1-2):33-42. doi: 10.1016/j.jri.2005.12.008. Epub 2006 Feb 20.
9
The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.CD94/NKG2C杀伤性凝集素样受体构成了一部分CD8+T细胞的另一种激活途径。
Eur J Immunol. 2005 Jul;35(7):2071-80. doi: 10.1002/eji.200425843.
10
Differential expression of KIR/NKAT2 and CD94 molecules on decidual and peripheral blood CD56bright and CD56dim natural killer cell subsets.蜕膜和外周血中CD56bright和CD56dim自然杀伤细胞亚群上KIR/NKAT2和CD94分子的差异表达
Fertil Steril. 2004 Mar;81 Suppl 1:863-8. doi: 10.1016/j.fertnstert.2003.10.019.

引用本文的文献

1
Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery.用于基于热疗的治疗和可控药物递送的磁性纳米材料。
Bioact Mater. 2025 Jul 26;53:591-629. doi: 10.1016/j.bioactmat.2025.07.033. eCollection 2025 Nov.
2
A new weapon: the application of tumor vaccines based on extracellular exosomal heat shock proteins in immunotherapy.一种新武器:基于细胞外外泌体热休克蛋白的肿瘤疫苗在免疫治疗中的应用。
Front Immunol. 2025 Jan 22;16:1510650. doi: 10.3389/fimmu.2025.1510650. eCollection 2025.
3
Effect of Benzyl Alcohol on Main Defense System Components of (Lepidoptera).
苯甲醇对鳞翅目(Lepidoptera)主要防御系统成分的影响。
Int J Mol Sci. 2024 Oct 18;25(20):11209. doi: 10.3390/ijms252011209.
4
Natural Killer cells at the frontline in the fight against cancer.自然杀伤细胞在抗击癌症的第一线。
Cell Death Dis. 2024 Aug 23;15(8):614. doi: 10.1038/s41419-024-06976-0.
5
Targeted Ferroptosis-Immunotherapy Synergy: Enhanced Antiglioma Efficacy with Hybrid Nanovesicles Comprising NK Cell-Derived Exosomes and RSL3-Loaded Liposomes.靶向铁死亡免疫治疗协同作用:包含 NK 细胞衍生外泌体和 RSL3 负载脂质体的混合纳米囊泡增强抗神经胶质瘤疗效。
ACS Appl Mater Interfaces. 2024 Jun 5;16(22):28193-28208. doi: 10.1021/acsami.4c04604. Epub 2024 May 22.
6
Diversity of extracellular HSP70 in cancer: advancing from a molecular biomarker to a novel therapeutic target.癌症中细胞外HSP70的多样性:从分子生物标志物迈向新型治疗靶点
Front Oncol. 2024 Apr 5;14:1388999. doi: 10.3389/fonc.2024.1388999. eCollection 2024.
7
Targeted Delivery of HSP70 to Tumor Cells via Supramolecular Complex Based on HER2-Specific DARPin9_29 and the Barnase:Barstar Pair.基于 HER2 特异性 DARPin9_29 和 Barnase:Barstar 对的超分子复合物实现 HSP70 靶向递送至肿瘤细胞。
Cells. 2024 Feb 9;13(4):317. doi: 10.3390/cells13040317.
8
Crosstalk Between NK Cell Receptors and Tumor Membrane Hsp70-Derived Peptide: A Combined Computational and Experimental Study.自然杀伤细胞受体与肿瘤膜 HSP70 衍生肽的串扰:一项计算与实验联合研究。
Adv Sci (Weinh). 2024 Apr;11(14):e2305998. doi: 10.1002/advs.202305998. Epub 2024 Jan 31.
9
Molecular Chaperone Receptors: An Update.分子伴侣受体:最新研究进展。
Methods Mol Biol. 2023;2693:193-208. doi: 10.1007/978-1-0716-3342-7_15.
10
Circulating Hsp70 Levels and the Immunophenotype of Peripheral Blood Lymphocytes as Potential Biomarkers for Advanced Lung Cancer and Therapy Failure after Surgery.循环 HSP70 水平与外周血淋巴细胞免疫表型作为晚期肺癌及术后治疗失败的潜在生物标志物。
Biomolecules. 2023 May 22;13(5):874. doi: 10.3390/biom13050874.